GRECCAR2 trial: details worthy of more attention - Authors' reply

Affiliations

¹ Departments of Colorectal Surgery, Haut-Lévèque Hospital, CHU Bordeaux, Université de Bordeaux, Pessac 33600, France. Electronic address: eric.rullier@chu-bordeaux.fr.
² Radiotherapy, Haut-Lévèque Hospital, CHU Bordeaux, Université de Bordeaux, Pessac 33600, France.
³ Departments of Colorectal Surgery, Haut-Lévèque Hospital, CHU Bordeaux, Université de Bordeaux, Pessac 33600, France.
⁴ Unité de Soutien Méthodologique à la Recherche Clinique et Epidémiologique du CHU de Bordeaux, Université Bordeaux, Bordeaux, France.

Comment

Eric Rullier et al. Lancet. 2018.

. 2018 Jan 13;391(10116):122-123.

doi: 10.1016/S0140-6736(18)30016-3.

¹ Departments of Colorectal Surgery, Haut-Lévèque Hospital, CHU Bordeaux, Université de Bordeaux, Pessac 33600, France. Electronic address: eric.rullier@chu-bordeaux.fr.
² Radiotherapy, Haut-Lévèque Hospital, CHU Bordeaux, Université de Bordeaux, Pessac 33600, France.
³ Departments of Colorectal Surgery, Haut-Lévèque Hospital, CHU Bordeaux, Université de Bordeaux, Pessac 33600, France.
⁴ Unité de Soutien Méthodologique à la Recherche Clinique et Epidémiologique du CHU de Bordeaux, Université Bordeaux, Bordeaux, France.

No abstract available

Comment on

Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.
Rullier E, Rouanet P, Tuech JJ, Valverde A, Lelong B, Rivoire M, Faucheron JL, Jafari M, Portier G, Meunier B, Sileznieff I, Prudhomme M, Marchal F, Pocard M, Pezet D, Rullier A, Vendrely V, Denost Q, Asselineau J, Doussau A. Rullier E, et al. Lancet. 2017 Jul 29;390(10093):469-479. doi: 10.1016/S0140-6736(17)31056-5. Epub 2017 Jun 7. Lancet. 2017. PMID: 28601342 Clinical Trial.
GRECCAR2 trial: details worthy of more attention.
Jia H, Guan Y, Zhu J. Jia H, et al. Lancet. 2018 Jan 13;391(10116):122. doi: 10.1016/S0140-6736(18)30015-1. Lancet. 2018. PMID: 29353620 No abstract available.